Condensed Interim Consolidated Balance Sheets (Unaudited) - USD ($)	Jan. 31, 2018	Jul. 31, 2017
Current Assets:
Cash and cash equivalents	$ 2,048,066	$ 2,879,165
Accounts receivable, net	175
Inventory, net	12,046	10,035
Other current assets	226,988	21,891
Total Current Assets	2,287,275	2,911,091
Property and equipment	48,857	573
Call option (Note 8)	3,257,655	4,237,829
Intangible asset (Note 8 and 9)	3,187,757	2,911,377
Patents, net	24,551	25,851
Other assets, net	7,824	7,824
TOTAL ASSETS	8,813,919	10,094,545
Current Liabilities:
Accounts payable and accrued expenses	10,384,280	10,172,610
Notes Payable	320,000
Loans from related parties (Note 3)	13,864,241	13,738,140
Total Current Liabilities	24,568,522	23,910,750
Warrants to be issued (Note 8)	46,303,223	66,060,026
Total Liabilities	70,871,744	89,970,776
Stockholders' Deficiency (Note 11):
Series F 9% Convertible Preferred Stock, $1,000 par value; authorized 4,150 shares, -0- and -0- issued shares at January 31, 2018 and July 31, 2017, respectively
Common stock, $.001 par value; authorized 750,000,000 and 2,450,000 shares at January 31, 2018 and July 31, 2017, respectively; 1,068,101 and 1,068,101 issued and outstanding at January 31, 2018 and July 31, 2017, respectively	1,068	1,068
Common stock payable	2,168,951	2,168,951
Additional paid-in capital	368,409,627	368,409,627
Accumulated deficit	(427,814,171)	(445,720,566)
Accumulated other comprehensive income	779,252	783,150
Non-controlling interest	(5,602,556)	(5,518,465)
Total Stockholders' Deficiency	(62,057,825)	(79,876,231)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	8,813,919	10,094,545
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
Series F 9% Convertible Preferred Stock, $1,000 par value; authorized 4,150 shares, -0- and -0- issued shares at January 31, 2018 and July 31, 2017, respectively
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
Series F 9% Convertible Preferred Stock, $1,000 par value; authorized 4,150 shares, -0- and -0- issued shares at January 31, 2018 and July 31, 2017, respectively
Series H Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
Series F 9% Convertible Preferred Stock, $1,000 par value; authorized 4,150 shares, -0- and -0- issued shares at January 31, 2018 and July 31, 2017, respectively	3	3
Series I Convertible Preferred Stock
Stockholders' Deficiency (Note 11):
Series F 9% Convertible Preferred Stock, $1,000 par value; authorized 4,150 shares, -0- and -0- issued shares at January 31, 2018 and July 31, 2017, respectively	$ 1	$ 1